Marshall Inpatient Physician | |
3120 North St Guntersville AL 35976-2912 | |
(256) 582-6561 | |
Not Available |
Full Name | Marshall Inpatient Physician |
---|---|
Speciality | Family Medicine |
Location | 3120 North St, Guntersville, Alabama |
Authorized Official Name and Position | Jeffrey M Saylor (MD/OWNER) |
Authorized Official Contact | 2565056826 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Marshall Inpatient Physician Po Box 150 Union Grove AL 35175-0150 Ph: (256) 505-6826 | Marshall Inpatient Physician 3120 North St Guntersville AL 35976-2912 Ph: (256) 582-6561 |
NPI Number | 1558553594 |
---|---|
Provider Enumeration Date | 08/14/2007 |
Last Update Date | 02/25/2020 |
Medicare PECOS PAC ID | 4587680798 |
---|---|
Medicare Enrollment ID | O20051018000187 |
News Archive
Proteins, unlike diamonds, aren't forever. And when they wear out, they need to be degraded in the cell back into amino acids, where they will be recycled into new proteins.
Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each case, and other actions, according to an international study led by Dana-Farber/Children's Hospital Cancer Center researchers. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Friday, Oct. 22.
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 4 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1558553594 | NPI | - | NPPES |
009933006 | Medicaid | AL | |
1174589410 | Other | AL | INDIVIDUAL NPI |
K643 | Other | AL | MEDICARE LEGACY NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 22856 (Alabama) | Primary |
Provider Name | Jeffrey M Saylor |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1174589410 PECOS PAC ID: 3274509336 Enrollment ID: I20040909000509 |
News Archive
Proteins, unlike diamonds, aren't forever. And when they wear out, they need to be degraded in the cell back into amino acids, where they will be recycled into new proteins.
Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each case, and other actions, according to an international study led by Dana-Farber/Children's Hospital Cancer Center researchers. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Friday, Oct. 22.
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 4 days ago
Provider Name | Leslie Jeffries |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1962894030 PECOS PAC ID: 3173837069 Enrollment ID: I20150805009623 |
News Archive
Proteins, unlike diamonds, aren't forever. And when they wear out, they need to be degraded in the cell back into amino acids, where they will be recycled into new proteins.
Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each case, and other actions, according to an international study led by Dana-Farber/Children's Hospital Cancer Center researchers. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Friday, Oct. 22.
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 4 days ago
News Archive
Proteins, unlike diamonds, aren't forever. And when they wear out, they need to be degraded in the cell back into amino acids, where they will be recycled into new proteins.
Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each case, and other actions, according to an international study led by Dana-Farber/Children's Hospital Cancer Center researchers. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Friday, Oct. 22.
Eisai Inc. announced today the results of its Phase 3 trial (Study 309), which showed that eribulin met the study's primary endpoint evaluating overall survival in patients who had advanced leiomyosarcoma (LMS) or adipocytic sarcoma (ADI), two types of advanced soft tissue sarcoma.
Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration of these cells while tumors formed and expanded.
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has granted approval for its Entovis pacemaker system with ProMRI technology.
› Verified 4 days ago
Marshall Medical Center North Jones Pediatric Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 45 Medical Park Dr, B, Guntersville, AL 35976 Phone: 256-571-8969 Fax: 256-571-8980 | |
Lakeside North Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 38 Rowe Dr, Guntersville, AL 35976 Phone: 256-571-8460 Fax: 256-571-8464 | |
Marshall Family Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7938 Alabama Hwy 69, Ste 350, Guntersville, AL 35976 Phone: 256-571-8500 Fax: 256-571-8502 | |
Marshall Medical Center North Family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7938 Al Highway 69, Suite 360, Guntersville, AL 35976 Phone: 256-571-8580 Fax: 256-571-8585 | |
Lakeside North Family Medicine, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 38 Rowe Dr, Guntersville, AL 35976 Phone: 256-571-8460 Fax: 256-571-8464 | |
Grant Family Practice Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1241 Blount Ave, Guntersville, AL 35976 Phone: 256-582-6377 Fax: 256-582-6376 | |
Lakeside North, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7938 Al Highway 69, Suite 130, Guntersville, AL 35976 Phone: 256-571-8460 Fax: 256-571-8464 |